Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 67.00 | |
25 mg | In stock | $ 138.00 | |
50 mg | In stock | $ 222.00 | |
100 mg | In stock | $ 328.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research. |
Targets&IC50 | Amidase:13 nM |
In vitro | AM 374 (0-9 nM) inhibits the degradation of anandamide in N18TG2 cells.[1] |
In vivo | AM 374 (20 μg ; intraventricular injection, once) has no effect on lever pressing in FR5, but when used in combination with anandamide (intraperitoneal injection), it reduces lever pressing.[2] |
Synonyms | HDSF, Hexadecanesulfonyl fluoride |
Molecular Weight | 308.5 |
Formula | C16H33FO2S |
CAS No. | 86855-26-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90.0 mg/mL (291.7 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AM 374 86855-26-7 Metabolism Neuroscience FAAH AM374 HDSF Hexadecanesulfonyl Fluoride AM-374 Hexadecanesulfonyl fluoride inhibitor inhibit